Breaking News Instant updates and real-time market news.

LVGO

Livongo Health

$70.22 /

+3.22 (+4.81%)

13:38
06/18/20
06/18
13:38
06/18/20
13:38

Livongo studies show remote technologies can utilize data insights for diabetes

Livongo Health announced the findings of two studies that demonstrate how remote monitoring technologies can utilize continuous and unique data insights via its AI+AI engine to better inform care decisions and outcomes. The research findings were presented at the American Diabetes Association's 80th Scientific Sessions: A Virtual Experience held on June 12-16. The first study, Predictors of Emergency Department and Inpatient Admissions after Hypo- and Hyperglycemic Events: Leveraging Remote Monitoring Data of People with Diabetes, included 7,633 study participants and used Livongo's cellular-enabled blood glucose monitor and remote monitoring capabilities to determine specific predictors which may lead to a hypoglycemic or hyperglycemic event. The study determined that a gap in days between checking, more 'Missed Medication' tags, fewer 'Before Breakfast' tags, new users of oral diabetes medications, and other factors were predictors associated with future emergency department and inpatient visits due to a hypoglycemic event. It also found that models pairing blood glucose values with rich data including time of day, meal tags, medication use, and feeling tags are more likely to predict those who are at a higher-risk of costly care interventions than models using blood glucose data alone. The second study, Is Activation, Behaviors, and Attitudes to Managing Care Associated with Utilization of a Remote Diabetes Monitoring Platform (RDMP) and Improvement of A1c, was conducted in collaboration with Eli Lilly & Company and included 1,089 participants. The study found a direct correlation between improvements in Diabetes Empowerment Scale-Short Form (DES-SF) and increased platform utilization. In addition, participants who used the Livongo platform more regularly and those who achieved measurable improvements in Diabetes Distress Scale 17 (DDS17) experienced better glycemic control. "Through Livongo's ability to collect a breadth of real-time data points, including meal tags and feeling tags, we are able to build out comprehensive Member profiles and direct interventions and features from our platform that lead to improved clinical outcomes," said Dr. Bimal Shah, Chief Medical Officer of Livongo and senior author of the studies. "As Livongo's AI+AI engine aggregates more data, our platform continues to improve by providing a more personalized care experience. We are able to leverage a combination of machine learning and clinical studies to continue to improve outcomes, drive down health care costs, improve utilization, and empower people to better manage their diabetes."

LVGO Livongo Health
$70.22 /

+3.22 (+4.81%)

06/12/20 SVB Leerink
Livongo Health price target raised to $65 from $55 at SVB Leerink
06/05/20 Cowen
Livongo Health initiated with Outperform at Cowen
06/03/20 Canaccord
Livongo Health price target raised to $69 from $65 at Canaccord
05/22/20 JPMorgan
Livongo Health price target raised to $63 from $36 at JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
Shift4 Payments says merchant transaction volume continues to increase » 09:29
07/06/20
07/06
09:29
07/06/20
09:29
FOUR

Shift4 Payments

$36.01 /

+2.005 (+5.90%)

Shift4 Payments said in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOUR Shift4 Payments
$36.01 /

+2.005 (+5.90%)

07/01/20 Citi
Shift4 Payments initiated with a Neutral at Citi
06/30/20 Morgan Stanley
Shift4 Payments initiated with an Equal Weight at Morgan Stanley
06/30/20 SunTrust
Shift4 Payments initiated with a Buy at SunTrust
06/30/20 RBC Capital
Shift4 Payments initiated with an Outperform at RBC Capital
  • 05
    Jun
FOUR Shift4 Payments
$36.01 /

+2.005 (+5.90%)

FOUR Shift4 Payments
$36.01 /

+2.005 (+5.90%)

Recommendations
Apple's build plan update negates speculation of cut, says Loop Capital » 09:26
07/06/20
07/06
09:26
07/06/20
09:26
AAPL

Apple

$364.11 /

+0.11 (+0.03%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$364.11 /

+0.11 (+0.03%)

AAPL Apple
$364.11 /

+0.11 (+0.03%)

06/26/20 Evercore ISI
Evercore upgrades Broadcom to Outperform, sees Apple sales driving upside
06/25/20 Wedbush
Wedbush boosts Apple target to $425, sees $2 trillion valuation in 2021
06/24/20 BMO Capital
Criteo downgraded to Market Perform from Outperform at BMO Capital
06/23/20 Baird
Apple price target raised to $390 from $320 at Baird
AAPL Apple
$364.11 /

+0.11 (+0.03%)

AAPL Apple
$364.11 /

+0.11 (+0.03%)

AAPL Apple
$364.11 /

+0.11 (+0.03%)

AAPL Apple
$364.11 /

+0.11 (+0.03%)

AAPL Apple
$364.11 /

+0.11 (+0.03%)

Hot Stocks
New Fortress Energy agrees to terminate Centrica LNG obligation for $105M » 09:25
07/06/20
07/06
09:25
07/06/20
09:25
NFE

New Fortress Energy

$12.62 /

-0.02 (-0.16%)

New Fortress Energy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFE New Fortress Energy
$12.62 /

-0.02 (-0.16%)

NFE New Fortress Energy
$12.62 /

-0.02 (-0.16%)

10/02/19
Fly Intel: Top five analyst initiations
10/01/19 BTIG
New Fortress Energy initiated with a Buy at BTIG
09/30/19 Citi
New Fortress Energy price target raised to $22 from $18 at Citi
09/20/19 Morgan Stanley
New Fortress Energy assumed with an Overweight at Morgan Stanley
NFE New Fortress Energy
$12.62 /

-0.02 (-0.16%)

General news
Treasury Action: supply hits again this week with $94 B in 3-, 10-, and 30-year auctions » 09:25
07/06/20
07/06
09:25
07/06/20
09:25

Treasury Action: supply…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Dominion sees FY20 EPS ~$3.50, consensus $4.35 » 09:24
07/06/20
07/06
09:24
07/06/20
09:24
D

Dominion

$82.68 /

+0.32 (+0.39%)

Sees FY21 EPS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

08:43 Today JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
08:39 Today JPMorgan
Dominion now positioned as 'best-in-class' utility, says JPMorgan
07:00 Today Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
06/09/20 Seaport Global
Dominion initiated with a Buy at Seaport Global
D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

Periodicals
Roche unit loses bid to halt sales of Amgen's Avastin biosimilar, Bloomberg says » 09:24
07/06/20
07/06
09:24
07/06/20
09:24
AMGN

Amgen

$258.40 /

+3.24 (+1.27%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Roche's (RHHBY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMGN Amgen
$258.40 /

+3.24 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

AMGN Amgen
$258.40 /

+3.24 (+1.27%)

07/02/20 Citi
Citi sees 'considerable amount of investor interest' coming back to Amgen
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Mizuho
Amgen patent win worth $5-$12 per share, says Mizuho
07/01/20 Goldman Sachs
Court ruling removes overhang for Amgen, says Goldman Sachs
RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
AMGN Amgen
$258.40 /

+3.24 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

AMGN Amgen
$258.40 /

+3.24 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

AMGN Amgen
$258.40 /

+3.24 (+1.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

AMGN Amgen
$258.40 /

+3.24 (+1.27%)

Conference/Events
NV5 Global participates in a conference call with Lake Street » 09:22
07/06/20
07/06
09:22
07/06/20
09:22
NVEE

NV5 Global

$51.16 /

+1.835 (+3.72%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVEE NV5 Global
$51.16 /

+1.835 (+3.72%)

NVEE NV5 Global
$51.16 /

+1.835 (+3.72%)

05/29/20 BofA
NV5 Global reinstated with a Neutral at BofA
05/19/20 Sidoti
NV5 Global initiated with a Buy at Sidoti
05/19/20 Sidoti
NV5 Global initiated with a Buy at Sidoti
04/08/20 Maxim
NV5 Global, ABM Industries, Badger Meter cut to Hold at Maxim
NVEE NV5 Global
$51.16 /

+1.835 (+3.72%)

NVEE NV5 Global
$51.16 /

+1.835 (+3.72%)

Earnings
Neovasc reports preliminary Q2 revenue $295,000, consensus $1.16M » 09:22
07/06/20
07/06
09:22
07/06/20
09:22
NVCN

Neovasc

$2.38 /

+ (+0.00%)

Revenues were negatively…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVCN Neovasc
$2.38 /

+ (+0.00%)

NVCN Neovasc
$2.38 /

+ (+0.00%)

05/08/20 H.C. Wainwright
Neovasc price target lowered to $5 from $9 at H.C. Wainwright
04/13/20
Fly Intel: Top five analyst initiations
04/13/20 Noble Capital
Neovasc initiated with an Outperform at Noble Capital
10/24/19 H.C. Wainwright
Neovasc initiated with a Buy at H.C. Wainwright
Hot Stocks
Dominion: Sale of gas operations is 'right step at right time'  09:21
07/06/20
07/06
09:21
07/06/20
09:21
D

Dominion

$82.68 /

+0.32 (+0.39%)

 
ShowHide Related Items >><<
D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

08:43 Today JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
08:39 Today JPMorgan
Dominion now positioned as 'best-in-class' utility, says JPMorgan
07:00 Today Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
06/09/20 Seaport Global
Dominion initiated with a Buy at Seaport Global
D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

Hot Stocks
Dominion: Sale of gas operations will enhance credit profile » 09:21
07/06/20
07/06
09:21
07/06/20
09:21
D

Dominion

$82.68 /

+0.32 (+0.39%)

Comments taken from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

08:43 Today JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
08:39 Today JPMorgan
Dominion now positioned as 'best-in-class' utility, says JPMorgan
07:00 Today Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
06/09/20 Seaport Global
Dominion initiated with a Buy at Seaport Global
D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

Hot Stocks
Genius Brands, POW! Entertainment announce agreement to create Stan Lee Universe » 09:20
07/06/20
07/06
09:20
07/06/20
09:20
GNUS

Genius Brands

$3.55 /

+1.245 (+54.13%)

Through a joint venture…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

Conference/Events
OraSure participates in a conference call hosted by Lake Street » 09:19
07/06/20
07/06
09:19
07/06/20
09:19
OSUR

OraSure

$12.01 /

+0.76 (+6.76%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OSUR OraSure
$12.01 /

+0.76 (+6.76%)

OSUR OraSure
$12.01 /

+0.76 (+6.76%)

06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
04/21/20 Stephens
OraSure resumed with an Equal Weight at Stephens
OSUR OraSure
$12.01 /

+0.76 (+6.76%)

  • 03
    Jun
OSUR OraSure
$12.01 /

+0.76 (+6.76%)

Options
Overnight activity included 806 trades in SPX and 16 trades in VIX » 09:18
07/06/20
07/06
09:18
07/06/20
09:18
SPX

S&P 500

$0.00 /

+ (+0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00 /

+ (+0.00%)

806 trades were executed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
VIX Volatility Index S&P 500 Options
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

VIX Volatility Index S&P 500 Options
$0.00 /

+ (+0.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Churchill Downs announces temporary suspension of operations at FL Calder Casino » 09:17
07/06/20
07/06
09:17
07/06/20
09:17
CHDN

Churchill Downs

$131.90 /

+0.18 (+0.14%)

Churchill Downs…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHDN Churchill Downs
$131.90 /

+0.18 (+0.14%)

CHDN Churchill Downs
$131.90 /

+0.18 (+0.14%)

07/01/20 JPMorgan
Churchill Downs price target raised to $148 from $138 at JPMorgan
04/06/20 Jefferies
Eldorado has 'considerable upside' from Caesars merger, says Jefferies
03/02/20 JPMorgan
Golden Entertainment downgraded to Neutral on downside risk at JPMorgan
03/02/20 JPMorgan
JPMorgan upgrades Churchill Downs on overblown COVID-19 concerns
CHDN Churchill Downs
$131.90 /

+0.18 (+0.14%)

CHDN Churchill Downs
$131.90 /

+0.18 (+0.14%)

Hot Stocks
Comtech awarded $1.5M contract for new Ka-band gateway TWTAs » 09:16
07/06/20
07/06
09:16
07/06/20
09:16
CMTL

Comtech

$16.01 /

-0.1 (-0.62%)

Comtech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMTL Comtech
$16.01 /

-0.1 (-0.62%)

CMTL Comtech
$16.01 /

-0.1 (-0.62%)

06/04/20 Northland
Comtech price target lowered to $24 from $27 at Northland
03/31/20 Citi
Comtech price target lowered to $17 from $34 at Citi
CMTL Comtech
$16.01 /

-0.1 (-0.62%)

CMTL Comtech
$16.01 /

-0.1 (-0.62%)

Hot Stocks
Canadian National to invest C$20M across New Bruunswick in 2020 » 09:15
07/06/20
07/06
09:15
07/06/20
09:15
CNI

Canadian National

$88.55 /

+0.51 (+0.58%)

Canadian National…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$88.55 /

+0.51 (+0.58%)

CNI Canadian National
$88.55 /

+0.51 (+0.58%)

06/23/20 Raymond James
Canadian National price target raised to C$125 from C$115 at Raymond James
06/19/20 National Bank
Canadian National price target raised to C$122 from C$111 at National Bank
06/19/20 RBC Capital
Canadian National price target lowered to C$125 from C$128 at RBC Capital
06/15/20 CIBC
Canadian National price target raised to C$125 from C$110 at CIBC
CNI Canadian National
$88.55 /

+0.51 (+0.58%)

Conference/Events
Morgan Stanley Latam financials analyst to hold analyst/industry conference call » 09:15
07/06/20
07/06
09:15
07/06/20
09:15

LatAm Financials Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Kulicke & Soffa increases share repurchase authorization by additional $100M » 09:13
07/06/20
07/06
09:13
07/06/20
09:13
KLIC

Kulicke & Soffa

$21.21 /

+0.45 (+2.17%)

Kulicke and Soffa…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLIC Kulicke & Soffa
$21.21 /

+0.45 (+2.17%)

KLIC Kulicke & Soffa
$21.21 /

+0.45 (+2.17%)

05/01/20 B. Riley FBR
Kulicke & Soffa price target raised to $29 from $26 at B. Riley FBR
01/31/20 Craig-Hallum
Kulicke & Soffa price target raised to $40 from $30 at Craig-Hallum
11/21/19
Fly Intel: Top five analyst upgrades
11/21/19 DA Davidson
Kulicke & Soffa upgraded to Buy from Neutral at DA Davidson
KLIC Kulicke & Soffa
$21.21 /

+0.45 (+2.17%)

Hot Stocks
Sinovac Biotech announces update to COVID-19 partnership with Butantan » 09:11
07/06/20
07/06
09:11
07/06/20
09:11
SVA

Sinovac Biotech

$0.00 /

+ (+0.00%)

Sinovac Biotech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SVA Sinovac Biotech
$0.00 /

+ (+0.00%)

SVA Sinovac Biotech
$0.00 /

+ (+0.00%)

Recommendations
H.C. Wainwright reiterates $28 target on Bellus despite Phase 2 miss » 09:10
07/06/20
07/06
09:10
07/06/20
09:10
BLU

Bellus Health

$12.01 /

+0.21 (+1.78%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Andrew Fein reiterates a Buy rating on Bellus Health with a $28 price target after the Phase 2 RELIEF study of BLU-5937 in chronic cough did not achieve the primary endpoint of reductions in awake cough frequency. The stock in premarket trading is down 75%, or $8.97, to $3.05. Despite the miss, a closer look at the data presented from high cough count patients coupled to a "well-tolerated" safety profile does not change the positive narrative for BLU-5937, Fein tells investors in a research note. The analyst says that while the data from both populations of RELIEF were "underwhelming," he's encouraged by the correlation between awake cough frequency at baseline versus reduction in awake cough frequency which was statistically significant. A closer look at how many patients cough is really driven by hypersensitization of P2X3 could be a differentiator and key criteria for future enrollment, adds Fein. He thinks that if BLU-5937 is able to show a meaningful reduction in cough frequency for high cough count patients while maintaining its "best-in-class" safety profile, Bellus is a "prime candidate for acquisition." Fein feels future label expansion of BLU-5937 "remains achievable beyond the current pipeline."

ShowHide Related Items >><<
BLU Bellus Health
$12.01 /

+0.21 (+1.78%)

BLU Bellus Health
$12.01 /

+0.21 (+1.78%)

06/26/20 H.C. Wainwright
Bellus Health initiated with a Buy at H.C. Wainwright
01/08/20 Guggenheim
Horizon Therapeutics named Guggenheim's best Emerging Pharma idea for 2020
09/30/19
Fly Intel: Top five analyst initiations
09/30/19 Jefferies
Jefferies sees potential double in Bellus Health, starts shares at Buy
  • 05
    Sep
Recommendations
Envision Solar price target raised to $17 from $15 at Maxim » 09:09
07/06/20
07/06
09:09
07/06/20
09:09
EVSI

Envision Solar

$8.67 /

-0.6 (-6.47%)

Maxim analyst Tate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVSI Envision Solar
$8.67 /

-0.6 (-6.47%)

EVSI Envision Solar
$8.67 /

-0.6 (-6.47%)

03/03/20
LD Micro to hold a virtual conference
  • 02
    Jul
Hot Stocks
AIM ImmunoTech signs material transfer, research agreement with Shionogi, NIID » 09:07
07/06/20
07/06
09:07
07/06/20
09:07
AIM

AIM ImmunoTech

$2.43 /

+0.01 (+0.41%)

AIM ImmunoTech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIM AIM ImmunoTech
$2.43 /

+0.01 (+0.41%)

AIM AIM ImmunoTech
$2.43 /

+0.01 (+0.41%)

04/06/20 Maxim
AIM ImmunoTech price target raised to $5 from $2 at Maxim
10/10/19 Maxim
AIM ImmunoTech has removed financing overhang, says Maxim
10/10/19 Maxim
AIM ImmunoTech upgraded to Buy from Hold at Maxim
Hot Stocks
SG Blocks executes $4M contract to manufacture a boutique in Florida » 09:07
07/06/20
07/06
09:07
07/06/20
09:07
SGBX

SG Blocks

$2.69 /

+0.01 (+0.37%)

SG Blocks announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGBX SG Blocks
$2.69 /

+0.01 (+0.37%)

  • 07
    May
  • 01
    Apr
  • 30
    Jul
SGBX SG Blocks
$2.69 /

+0.01 (+0.37%)

On The Fly
Fly Intel: Pre-market Movers » 09:06
07/06/20
07/06
09:06
07/06/20
09:06
UBER

Uber

$30.66 /

+0.24 (+0.79%)

, REGN

Regeneron

$620.76 /

+11.54 (+1.89%)

, BDX

Becton Dickinson

$245.09 /

+3.57 (+1.48%)

, SBH

Sally Beauty

$13.08 /

+0.17 (+1.32%)

, DTIL

Precision BioSciences

$8.44 /

+0.06 (+0.72%)

, SLCA

U.S. Silica

$3.36 /

+0.05 (+1.51%)

, SPOT

Spotify

$271.59 /

+12.63 (+4.88%)

, D

Dominion

$82.68 /

+0.32 (+0.39%)

, OBSV

ObsEva

$6.15 /

+0.17 (+2.84%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
UBER Uber
$30.66 /

+0.24 (+0.79%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

DTIL Precision BioSciences
$8.44 /

+0.06 (+0.72%)

SLCA U.S. Silica
$3.36 /

+0.05 (+1.51%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

D Dominion
$82.68 /

+0.32 (+0.39%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

08:16 Today Wedbush
Uber's acquisition of Postmates 'a smart strategic move,' says Wedbush
07/01/20 BTIG
Uber consensus likely aggressive, says BTIG
06/30/20 SunTrust
Uber shouldn't face regulatory issues if it buys Postmates, says Suntrust
06/25/20 Deutsche Bank
Yandex interest in Uber's minority stake modest positive, says Deutsche Bank
REGN Regeneron
$620.76 /

+11.54 (+1.89%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

07/02/20 Wells Fargo
Becton rallies after Wells says rapid COVID test may come very soon
07/02/20 Wells Fargo
Becton rapid antigen COVID test may be available very soon, says Wells Fargo
06/25/20 Raymond James
Becton Dickinson price target lowered to $265 from $290 at Raymond James
06/01/20
Fly Intel: Top five analyst initiations
SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

06/04/20 Oppenheimer
Sally Beauty upgraded to Outperform at Oppenheimer
06/04/20 Oppenheimer
Sally Beauty upgraded to Outperform from Perform at Oppenheimer
04/27/20 DA Davidson
Sally Beauty price target lowered to $10 from $14.50 at DA Davidson
04/20/20 Raymond James
Sally Beauty preliminary Q2 not as bad as feared, says Raymond James
DTIL Precision BioSciences
$8.44 /

+0.06 (+0.72%)

05/18/20 H.C. Wainwright
Precision BioSciences could have 'significant upside,' says H.C. Wainwright
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
03/04/20 Stifel
Precision BioSciences initiated with a Buy at Stifel
SLCA U.S. Silica
$3.36 /

+0.05 (+1.51%)

06:26 Today Evercore ISI
U.S. Silica upgraded to In Line from Underperform at Evercore ISI
03/19/20 Barclays
U.S. Silica upgraded to Equal Weight from Underweight at Barclays
03/11/20 Tudor Pickering
U.S. Silica downgraded to Hold from Buy at Tudor Pickering
03/09/20 Evercore ISI
U.S. Silica downgraded to Underperform from Outperform at Evercore ISI
SPOT Spotify
$271.59 /

+12.63 (+4.88%)

06:44 Today JPMorgan
Spotify price target raised to $305 from $185 at JPMorgan
06:16 Today Bernstein
Bernstein doubts Spotify will make money off podcasts, downgrades to sell
05:17 Today Bernstein
Spotify downgraded to Underperform from Market Perform at Bernstein
07/01/20 Wells Fargo
Spotify price target raised to $175 from $130 at Wells Fargo
D Dominion
$82.68 /

+0.32 (+0.39%)

08:43 Today JPMorgan
EQT could benefit from pipeline cancellation, says JPMorgan
08:39 Today JPMorgan
Dominion now positioned as 'best-in-class' utility, says JPMorgan
07:00 Today Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
06/09/20 Seaport Global
Dominion initiated with a Buy at Seaport Global
OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

03/24/20 Wedbush
ObsEva price target lowered to $34 from $40 at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 after pipeline update at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 from $36 at Wedbush
12/19/19 H.C. Wainwright
ObsEva price target raised to $40 from $36 at H.C. Wainwright
UBER Uber
$30.66 /

+0.24 (+0.79%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

DTIL Precision BioSciences
$8.44 /

+0.06 (+0.72%)

SLCA U.S. Silica
$3.36 /

+0.05 (+1.51%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

D Dominion
$82.68 /

+0.32 (+0.39%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

  • 27
    May
  • 21
    May
  • 11
    Feb
  • 07
    Nov
  • 06
    Nov
UBER Uber
$30.66 /

+0.24 (+0.79%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

D Dominion
$82.68 /

+0.32 (+0.39%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

BDX Becton Dickinson
$245.09 /

+3.57 (+1.48%)

SBH Sally Beauty
$13.08 /

+0.17 (+1.32%)

DTIL Precision BioSciences
$8.44 /

+0.06 (+0.72%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

D Dominion
$82.68 /

+0.32 (+0.39%)

UBER Uber
$30.66 /

+0.24 (+0.79%)

REGN Regeneron
$620.76 /

+11.54 (+1.89%)

SPOT Spotify
$271.59 /

+12.63 (+4.88%)

D Dominion
$82.68 /

+0.32 (+0.39%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

Conference/Events
Genius Brands to host business news update conference call » 09:05
07/06/20
07/06
09:05
07/06/20
09:05
GNUS

Genius Brands

$3.55 /

+1.245 (+54.13%)

Chairman & CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

GNUS Genius Brands
$3.55 /

+1.245 (+54.13%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.